Global, National, Regional

Similar documents
Global, National, Regional

4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB

THE FEW REMAINING (IMPOSSIBLE) CASES

Epidemiology of Tuberculosis in the Northeast Region of the United States Surveillance Data Source. States included in the Northeast Region

Tuberculosis Epidemiology

The epidemiology of tuberculosis

Chapter 1 Overview of Tuberculosis Epidemiology in the United States

The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America

Drug-resistant Tuberculosis

Recipients of development assistance for health

Disclosures. TB and CoMorbidities Challenges and Opportunities. Burden of TB. Outline of the lecture. Target testing for TB Infection TB HIV 3/25/2012

Substance Abuse and Tuberculosis Springfield, IL April 27, 2011

The American Experience with TB Elimination

Drug-resistant Tuberculosis

Appendix 3 Sample size and cost of surveys

TB Nurse Case Management San Antonio, Texas July 18 20, 2012

TB EPIDEMIOLOGY. Outline. Estimated Global TB Burden, TB epidemiology

2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges

Epidemiology of TB: A Local and National Overview

Tuberculosis in Alameda County, 2009

The WHO END-TB Strategy

511,000 (57% new cases) ~50,000 ~30,000

The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific

Controlling TB in the era of HIV

Substance Abuse and Tuberculosis Oklahoma City, Oklahoma November 17, 2010

TB and Diabetes Intersection of Two Diseases

The Epidemiology of Tuberculosis in Minnesota,

The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific

HIV/AIDS and other Sexually Transmitted Diseases (STDs) in the Southern Region of the United States: Epidemiological Overview

XDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps

What can be done against XDR-TB?

#4 (Tuberculosis OR TB OR Pulmonary Tuberculosis OR Multi-Drug Resistant Tuberculosis OR MDR OR Extremely-Drug Resistant Tuberculosis or XDR)

WHAT'S IN A NUMBER? TWO RECENT REPORTS ESTIMATING CHILDHOOD TB CASES.

Tuberculosis Populations at Risk

GLOBAL TUBERCULOSIS REPORT EXECUTIVE SUMMARY

ACEP National H1N1 Preparedness Survey Results

Stop TB Working Group on DOTS-Plus for MDR-TB Strategic Plan

La Lotta alla Tubercolosi. Matteo Zignol and Mario C. Raviglione Stop TB Department WHO, Geneva, Switzerland. Geneva March 2012

2014 Annual Report Tuberculosis in Fresno County. Department of Public Health

ANNUAL REPORT EXECUTIVE SUMMARY. The full report is available at DECEMBER 2017

World Health Organization 2013

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director

Overview of the Presentation

2015 Annual Report Tuberculosis in Fresno County. Department of Public Health

Main global and regional trends

TB Intensive Minneapolis, Minnesota September 23-26, 2008

Please evaluate this material by clicking here:

EPIDEMIOLOGY OF TUBERCULOSIS AND the IMPACT ON CHILDREN

Annual Tuberculosis Report Oregon 2007

WHO Global Task Force on TB Impact Measurement An overview

Global TB Burden, 2016 estimates

ANNUAL TUBERCULOSIS REPORT OREGON Oregon Health Authority Public Health Division TB Program November 2012

2018 HPV Legislative Report Card

TB EPIDEMIOLOGY: IMPACT ON CHILDREN. Anneke C. Hesseling Desmond Tutu TB Centre Department Paediatrics and Child Health Stellenbosch University

AAll s well that ends well; still the fine s the crown; Whate er the course, the end is the renown. WILLIAM SHAKESPEARE, All s Well That Ends Well

TB Disease Prevalence Survey - Progress Report

The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps

CHAIR: DR JORGE SAMPAIO, UN SECRETARY-GENERAL'S SPECIAL ENVOY TO STOP TB AND FORMER PRESIDENT OF THE PORTUGUESE REPUBLIC

A Review on Prevalence of TB and HIV Co-infection

Mathematical modelling approach to estimating TB burden in children Pete Dodd (University of Sheffield) & James Seddon (Imperial College London)

2016 Annual Tuberculosis Report For Fresno County

Global MDR-TB Update GIDC. Paul Nunn, MA, FRCP(UK) Director, Global Infectious Disease Consulting London, UK

Technology and innovation: Changing dynamics of TB control. Karin Weyer

Investing for Impact

HEALTH OF WOMEN AND CHILDREN REPORT

TB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO

Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer

Revitalising community engagement for TB and TB/HIV prevention, diagnosis and treatment

TUBERCULOSIS (TB) SCREENING AND TESTING

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN

Women s health status is one of the strongest determinants of how women use the health care system. The

7.5 South-East Asian Region: summary of planned activities, impact and costs

Drug resistance TB in People Living with HIV: research questions and priorities.

HIV in Prisons, 2000

Cirrhosis and Liver Cancer Mortality in the United States : An Observational Study Supplementary Material

Tuberculosis in Alameda County, 2012

Radiation Therapy Staffing and Workplace Survey 2016

An Unhealthy America: The Economic Burden of Chronic Disease Charting a New Course to Save Lives and Increase Productivity and Economic Growth

Tuberculosis in Chicago 2007

Global reductions in measles mortality and the risk of measles resurgence

Updates on the global TB Global TB burden Policy response Treatment approaches

Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs

TB Transmission, Pathogenesis & Infection Control

Global TB control: Current status with particular attention to TB among women and children

Name of the presenter

ON THE ROAD TO ENDING TB HIGHLIGHTS FROM THE 30 HIGHEST TB BURDEN COUNTRIES

In 2013, around 12.9 million people living with HIV had access to antiretroviral therapy.

TB epidemic and progress towards the Millennium Development Goals

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB

Prevalence of Self-Reported Obesity Among U.S. Adults by State and Territory. Definitions Obesity: Body Mass Index (BMI) of 30 or higher.

Ending the AIDS Epidemic in Adolescents

Tuberculosis Surveillance

Update on Progress and Challenges in Achieving Measles and Rubella Targets

2003 National Immunization Survey Public-Use Data File

Tuberculosis-related deaths in people living with HIV have fallen by 36% since 2004.

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION

DRUG RESISTANCE IN TUBERCULOSIS CONTROL. A GLOBAL AND INDIAN SITUATION

TB the basics. (Dr) Margaret (DHA) and John (INZ)

XDR and MDR TB Urgent Research Priorities. Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine

Tuberculosis: The Big Picture And Challenge of Drug-resistance

Transcription:

Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology is an Important Part of TB Control The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB morbidity Identifying people or groups of people at risk for TB Understanding how the disease is transmitted Prioritizing cases Planning appropriate use of staff and resources History of TB 17 th -18 th centuries: TB took 1 in 5 adult lives 17-19: 1 billion died of TB 1882: Robert Koch discovered the TB bacillus (7 million deaths) 1873-1945: Sanatorium treatment 1944: Development of streptomycin 1952: Development of isoniazid 1

Burden of Tuberculosis: Global Why do we need to care about TB in the rest of the world? The Global Burden of TB, 29 Estimated 9.4 million new cases (range 8.9-9.9 million) 137/1, population 7.9 million (86%) in Asia and sub-saharan Africa 12% of new TB cases are HIV-infected (1.-1.2 1 million new cases ) 79% of these HIV-positive cases were in the African Region and 11% were in the South-East Asia Region. 38% of new TB cases in Africa are HIV-infected In 24, just 4% of TB patients in the region were tested for HIV; in 27 that number rose to 37%, with several countries testing more than 75% of TB patients for their HIV status Why do we need to care about TB in the rest of the world? The Global Burden of TB, 29 1.7 million people died of TB (98% of deaths in developing world) - 21 global l TB control report also reveals that t one out of four TB deaths is HIV-related, twice as many as previously recognized. The 4, deaths among HIVpositive incident TB cases equate to 33% of HIV-positive incident cases of TB and 23% of the estimated 1.7 million deaths in 21. The Global Burden of TB, 28 "These findings point to an urgent need to find, prevent and treat tuberculosis in people living with HIV and to test for HIV in all patients with TB in order to provide prevention, treatment and care. Countries can only do that through stronger collaborative programmes and stronger health systems that address both diseases," said Dr Margaret Chan, Director-General of WHO. March 24, 21 1/3 of the world is infected with M. Tb (2 billion people) 2

Beware of Data Estimated TB Incidence Rates, 29 (per 1,) Estimated TB Burden, 21 22 high burden countries * # of new cases # of new cases 1. India 1,982,628 12. Vietnam 174,593 2. China 1,31,322 13. Russia 15,898 3. South Africa 476,732 14. Kenya 127,14 4. Nigeria 457,675 15. Uganda 98,356 5. Indonesia 429,73 16. Zimbabwe 94,94 6. Pakistan 49,392 17. Mozambique 94,45 7. Bangladesh 359,671 18. Thailand 92,87 8. Ethiopia 297,337 19. Brazil 89,21 9. Philippines 257,317 2. Tanzania 8,653 1. DR Congo 245,162 21. Cambodia 71,382 11. Myanmar 2,6 22. Afghanistan 51,456 Global TB Control: Background *Ranks based on numbers of smear-positive cases WHO Update, 21 3

International TB Control Strategy Stop TB Strategy: 26 - current 1. Pursue high-quality DOTS expansion and enhancement 2. Address TB/HIV, MDR-TB and other challenges 3. Contribute to health system strengthening 4. Engage all care providers 5. Empower people with TB, and communities 6. Enable and promote research Emergence of Worst-Case TB Scenarios Emergence of Worst-Case TB Scenarios Co-infection between TB and HIV Multidrug-resistant TB (MDR-TB) Resistance to isoniazid and rifampin the 2 most powerful anti-tb drugs Extensively-drug resistant TB (XDR-TB) MDR-TB plus resistance to any fluoroquinolone and at least 1 second-line injectable (amikacin, kanamycin, capreomycin) The Global Burden of TB/HIV 1/3 of 33 million people living with HIV/AIDS co-infected with TB (>1 million people) Without treatment, 9% will die within months HIV and TB form a lethal combination, each speeding the other's progress TB is the leading cause of death among HIVpositive people (up to 5% of all patients worldwide) 4

Estimated HIV Prevalence in New TB Cases, 29 (per 1,) Global Multidrug-Resistant TB http://whqlibdoc.who.int/publications/21/9789241599191_eng.pdf Estimated 39, 51, MDR- TB cases in 28 (best estimate, 44, cases 3.6%) HIV Prevalence in New Adult TB Cases (%), 29 Africa 46 Americas 17 Eastern Mediterr. 3.6 Europe 4.9 South-East Asia 14 Western Pacific 11 Global 12 Global prevalence: could be as high as 1 million China, India, the Russian Federation and South Africa had largest number of MDR-TB cases Hot spots for MDR-TB: countries of the former Soviet Union 27 MDR-TB High Burden Countries Global Extensively Drug-Resistant TB 21 Global Report: % of XDR-TB among MDR-TB Japan: 3.9% Tajikistan: 21.% Ukraine: 15.% United States: from 1993-21, 57 cases of XDR-TB As of July 21, 58 countries and territories reported at least 1 case of XDR-TB 5

TB Remains a Global Killer Why does TB infect one-third of the world s population and still remain a global health threat despite the fact that highly cost-effective drugs are available to eradicate it Challenges in TB Control Burden of Tuberculosis: Insufficient financial and human resources Inadequate healthcare infrastructure Weak laboratory capacity and lack of new rapid diagnostic tools Smear negative and drug susceptibility testing Lack of new drugs that would cure TB in a shorter time Lack of effective vaccine that would prevent spread of infection Minimal social mobilization for TB control and minimal population awareness stigma HIV and MDR/XDR threats National 6

TB Morbidity United States, 22 21 Year No. Rate* 22 15,56 5.2 23 14,837 5.1 24 14,51 4.9 25 14,65 4.7 26 13,754 4.6 27 13,299 4.4 28 12,898 4.2 29 11,54 3.8 21 11,181 3.6 *Cases per 1,, updated as of March 25, 211. Lowest since 1953 record decline of 11.4% TB Case Rates,* United States, 21 TB rate ranged from.6 (Maine) to 8.8 (Hawaii) 32 states had lower rates in 21 than in 29 18 and DC had higher rates 4 states (California, Florida, New York, Texas) each reported more than 5 cases Combined, these 4 states accounted for nearly half (49.2%) of all TB cases in the US TB Rate Trends in the U.S. 21 TB case rate (3.6) represent a 3.9% decline from 29 and lowest recorded since national reporting began in 1953 BUT progress has slowed in recent years Average annual percentage decline in TB rate slowed from 7.3% per year during 1993-2 to 3.8% during 2-28 Groups with disproportionate burden of TB disease in the US in 29: Hispanics: 7 times higher than non-hispanic whites Blacks: 8 times higher Asian: 25 times higher Non-US born: 11 times higher than US-born Greatest disparity in TB rates among US-born Number & Rate of TB Cases in U.S.-born vs. Non-U.S.-born Persons United States, 1993 21* *Updated March 211 with provisional 21 data 7

Globalization of Economy = Globalization of Health Risks Increasing percentage of cases in the US observed among non-us-born (6.5%: 21) In 29, 35% of non-us-born TB cases developed the disease within 4 years of immigrating to US More than half (5.3%) of non-us-born TB cases were reported in persons from 4 countries Mexico (23.%) Philippines (11.%) India (8.6%) Vietnam (7.7%) Trends in TB Cases in Non-U.S.-born Persons, United States, 1987 21* No. of Cases Percentage 1, 7 8, 6 5 6 6, 4 4, 3 2 2, 1 1988 199 1992 1994 1996 1998 2 22 24 26 28 21 No. of Cases Percentage of Total Cases *Updated March 211 with provisional 21 data No. of MD DR-TB Cases Total MDR-TB Cases in U.S.-born vs. Non-U.S.-born Persons United States, 1993 29* 5 4 3 2 1 1993 1995 1997 1999 21 23 25 27 29 Trends in MDR-TB Cases in the U.S. 1997-21 Proportion of MDR-TB cases among persons without a previous history of TB has remained stable at 1% since 1997 BUT is 4-5 times higher for persons with a previous history of TB MDR-TB disproportionately impacts non-us-born persons Account for 84.5% of MDR-TB cases in 29 One new XDR-TB case reported in 21 US-born Non-US born *Most recent year for which complete drug susceptibility data are available 8

Estimated HIV Co-infection in Persons Reported with TB United States, 1993 29* Burden of Tuberculosis % Co-i infection 3 2 1 1993 1996 1999 22 25 28 All Ages Aged 25 44 Regional *Data for all years updated through July 1, 21 Note: Minimum estimates based on reported HIV-positive status among all TB cases in the age group. Number of TB Cases and Case Rate, Northeast Region US, 29 No. of Cases Case Rate 1,2 1, 1 8 8 6 6 4 4 2 2 NY NJ MA PA MD OH MI IN CT DC RI WV DE NH ME VT No. of Cases Case Rate 9

Trends in TB Cases and Case Rate, Northeast Region US, 28 vs. 29 Percentage of non-us-born Persons with TB Northeast Region, US, 29 2 reporting areas had an increased TB case rate in 29 compared to 28 Indiana and Vermont 18 reporting areas had a decreased TB case rate in 29 compared to 28 New York, New Jersey, Massachusetts, Pennsylvania, Maryland, Ohio, Michigan, Connecticut, District of Columbia, Rhode Island, Delaware, West Virginia, New Hampshire and Maine No. of TB Cases 12 9 6 3 71% 74% 51% 69% 74% 69% 78% 9% 68% 82% 67% NY NJ PA MD OH MI MA IN CT DC RI WV DE ME NH VT US-born Non-US born MDR-TB in Northeast Region, US, 29 Initial drug-susceptibility testing performed With the exception of VT (5%), all reporting areas had at least 75% culture positive cases tested 9 reporting areas reported MDR-TB cases 8 reported no MDR-TB cases (CT, DE, DC, ME, NH, RI, WV) Data not available for VT Area # MDR % IN 3 3.1 MD 2 1.2 MA 3 1.7 MI 1.9 NJ 9 3. NYS 4 2.2 NYC 8 1.5 OH 2 1.3 PA 2 1.5 TB Cases & Percentages among Persons Aged 25-44 by HIV Status, Northeast Region, US, 29 Area % of cases w/ HIV status No. HIVpositive (%) CT 7.3 N/A DE 1. 1(11.1) DC 71.4 N/A IN 97.2 5 (14.3) ME () MD 95.7 11 (12.5) MA 72.6 N/A MI 8.4 4 (9.8) NH 1. 1 (5.) N/A: data not available Area % of cases w/ HIV status No. HIVpositive (%) NJ 85.1 18 (12.6) NYS 89.4 6 (7.9) NYC 89.8 37 (14.5) OH 83.3 7 (12.7) PA 83.8 4 (7.) RI 1. 2 (22.2) VT. N/A WV 83.3 () 1

Why do we need to care about TB in the rest of the world? Have germs, will travel Migrating populations in the 199s Diseases don t need visas 4 Compared x increase to 196-75, in volume four-fold as compared increase to in 196 migration-75 Source: Population Action International 1994 Immigration Immigration has played an important role in American history, and the US continues to have the most open immigration policy in the world Immigrants account for 1 in 8 US residents 29 census--37,6,556 6 US pop 38,452,822 FB (12.5%) States in the NE Region with the highest percent non-us born (29) #2 New York (21.3%) #3 New Jersey (2.2%) #9 Massachusetts (14.4%) #12 Maryland (12.9%) #3 Pennsylvania (5.3%) Applicants for U.S. immigration being screened according to the 27 Technical Instructions for TB screening and treatment 11

Medical Examinations TB Screening Medical Examination Who is required to have a medical examination for migration to the United States? CDC Immigration Requirements: 27 Technical Instructions for TB Screening & Treatment TB Classifications No TB classification normal TB screening exam Class A TB disease, smear and/or culture positive Class B1 TB Pulmonary No treatment: abnormal CXR, smear & culture negative Completed TB treatment Class B1 TB Extrapulmonary Class B2 TB LTBI evaluation TST 1mm or positive IGRA Class B3 TB Contact evaluation International Travel International travel 51.1 million international visitors in 26 9% anticipated increase in next 5 years Travelers from China increased 24% Expected visitors from India to increase 5% and visitors from China to increase 64% by 213 35.2 million US citizens traveled overseas in 28 Office of Travel and Tourism Industries 12

International Travel Increasing Risks for All 1. Failure to develop measures to prevent and treat TB everywhere threatens our ability to control the disease anywhere 2. The elimination of TB in the Northeast Region, and the U.S. will depend increasingly on the elimination of TB among the non-us-born TB ANYWHERE IS TB EVERYWHERE! Office of Travel and Tourism Industries TUBERCULOSIS Contact: Ed Zuroweste MD 814-238-6566 kugelzur@migrantclinician.org 13